Benitec Biopharma (BNTC) Return on Equity [ROE] (2020 - 2025)
Benitec Biopharma (BNTC) reported Return on Equity [ROE] of -37.32% for FY2026 (year ended Jun 30, 2026), up 20.46 percentage points from -57.79% in FY2025.
Powered by 
Analysis
Benitec Biopharma (BNTC) Return on Equity [ROE] (2020 - 2025) Analysis & Trends
Dating back to FY2020, Benitec Biopharma's Return on Equity [ROE] record includes 7 fiscal years.
- Return on Equity [ROE] has increased for three consecutive fiscal years, with a five-year change of +52.57 percentage points (FY2021 to FY2026).
- The FY2026 figure ranks as the highest annual Return on Equity [ROE] in data going back to FY2020.
- According to Business Quant data, Return on Equity [ROE] came in at -57.79% in FY2025 (+37.01 pp), -94.79% in FY2024 (+1142.62 pp), -1237.42% in FY2023 (-1081.43 pp) and -155.98% in FY2022 (-66.09 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Benitec Biopharma | 465.58 Mn | 465.58 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -30.75% |
| Sep 30, 2025 | -42.57% |
| Jun 30, 2025 | -37.58% |
| Mar 31, 2025 | -37.27% |
| Dec 31, 2024 | -37.52% |
| Sep 30, 2024 | -40.22% |
| Jun 30, 2024 | -76.56% |
| Mar 31, 2024 | -159.38% |
| Dec 31, 2023 | -114.84% |
| Sep 30, 2023 | -181.03% |
| Jun 30, 2023 | -776.44% |
| Mar 31, 2023 | -281.16% |
| Dec 31, 2022 | -155.78% |
| Sep 30, 2022 | -201.35% |
| Jun 30, 2022 | -343.30% |
| Mar 31, 2022 | -184.92% |
| Dec 31, 2021 | -131.54% |
| Sep 30, 2021 | -88.65% |
| Jun 30, 2021 | -87.89% |
| Mar 31, 2021 | -98.84% |
API Access
Benitec Biopharma Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BNTC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "BNTC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BNTC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();